CompletedNot Applicable

THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG

Turkey (Türkiye)177 participantsStarted 2025-10-16

Plain-language summary

Background: University students are at high risk for HPV infection, while HPV vaccination rates remain low. Message framing strategies may influence vaccination-related perceptions and intentions. Objective: This study aims to compare the effects of gain- and loss-framed HPV vaccination messages on HPV risk perception, HPV knowledge, and vaccination intention among university students. Methods: This randomized controlled experimental study includes university students from the health sciences faculty of a foundation university. Participants are assigned to gain-framed, loss-framed, and control groups. Data are collected using the Human Papillomavirus Knowledge Scale and the HPV Risk Perception Questionnaire. Statistical analyses include one-way ANOVA, two-way ANOVA, and Chi-square tests. The study is designed in accordance with CONSORT 2010 and EQUATOR Network reporting guidelines. Keywords: message framing; gain-loss framing; human papillomavirus; vaccination

Who can participate

Age range

18 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 years or older * Voluntarily agrees to participate in the study * Has not received formal education about HPV through a course or class Exclusion Criteria: * Has received the HPV vaccine * Has participated in formal education about HPV through a course or class * Has a current or previous positive HPV test result or HPV diagnosis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

HPV vaccination intention

Timeframe: Immediately after message exposure

Trial details

NCT IDNCT07614009

SponsorAnkara Medipol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-25

View on ClinicalTrials.gov More Human Papillomavirus (HPV) Vaccination trials